Matches in DBpedia 2014 for { ?s ?p Resimmune is an experimental anti-T cell immunotoxin that is being investigated for treatment of T cell blood cancers such as cutaneous T cell lymphoma. It was developed by Doctors Neville, Woo, and Liu while at the National Institutes of Health (NIH) and is under exclusive license to Angimmune, LLC. The therapy has potential applications for lymphomas and T cell driven autoimmune diseases, including multiple sclerosis, and graft-versus-host disease following stem cell or bone marrow transplant.. }
Showing items 1 to 2 of
2
with 100 items per page.
- Resimmune abstract "Resimmune is an experimental anti-T cell immunotoxin that is being investigated for treatment of T cell blood cancers such as cutaneous T cell lymphoma. It was developed by Doctors Neville, Woo, and Liu while at the National Institutes of Health (NIH) and is under exclusive license to Angimmune, LLC. The therapy has potential applications for lymphomas and T cell driven autoimmune diseases, including multiple sclerosis, and graft-versus-host disease following stem cell or bone marrow transplant.".
- Resimmune comment "Resimmune is an experimental anti-T cell immunotoxin that is being investigated for treatment of T cell blood cancers such as cutaneous T cell lymphoma. It was developed by Doctors Neville, Woo, and Liu while at the National Institutes of Health (NIH) and is under exclusive license to Angimmune, LLC. The therapy has potential applications for lymphomas and T cell driven autoimmune diseases, including multiple sclerosis, and graft-versus-host disease following stem cell or bone marrow transplant.".